Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82,773,190
-
Total 13F shares
-
25,837,623
-
Share change
-
+1,664,051
-
Total reported value
-
$433,614,752
-
Put/Call ratio
-
105%
-
Price per share
-
$16.78
-
Number of holders
-
107
-
Value change
-
+$21,311,417
-
Number of buys
-
69
-
Number of sells
-
33
Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q2 2017
As of 30 Jun 2017,
Editas Medicine, Inc. - Common Stock (EDIT) was held by
107 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,837,623 shares.
The largest 10 holders included
FMR LLC, Polaris Venture Management Co. VI, L.L.C., BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, Viking Global Investors LP, DEERFIELD MANAGEMENT CO, PRICE T ROWE ASSOCIATES INC /MD/, EcoR1 Capital, LLC, and STATE STREET CORP.
This page lists
107
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.